Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism

Diagnostic Molecular Pathology

Volumn 9, Issue 1, 2000, Pages 20-25

  Iacopetta, Barry ^a   Elsaleh, Hany ^a,b   Grieu, Fabienne ^b   Joseph, David ^b   Sterrett, Greg ^b   Robbins, Peter ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Adjuvant chemotherapy; Early stage breast cancer; p53; Prognostic factor

Indexed keywords

ARTICLE; BREAST CANCER; DISEASE ASSOCIATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; FEMALE; FLUORESCENCE; GENES, P53; HUMANS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0034009432     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200003000-00004     Document Type: Article

References (31)

1. Ahrendt SA, Halachmi S, Chow JT, et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci USA 1999;96:7382-7.
2. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-68.
3. Andersen T, Holm R, Nesland J, et al. Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 1993;68:540-8.
4. Archer S, Eliopoulos A, Spandidos D, et al. Expression of ras, p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br J Cancer 1995;72:1259-66.
5. Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1995;1:1029-34.
6. Bosari S, Viale G. The clinical significance of p53 aberrations in human tumors. Virchows Arch A 1995;427:229-41.
7. Caleffi M, Teague M, Jensen R, et al. P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer 1994;73:2147-56.
8. Clark GM. Do we really need prognostic factors for breast cancer? Breast Cancer Res Treat 1994:30:117-26.
9. Cuny M, Kramar A, Courjal F, et al. Differential prognostic significance of p53 mutations and DNA amplification of eight different loci in breast cancer patients. Cancer Res (in press).
10. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998;352:930-42.
11. Elledge R, Fuqua S, Clark G, et al. Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res Treat 1993;26:225-35.
12. Ellison JS, Dean M, Goldman D. Efficacy of fluorescence-based PCR-SSCP for detection of point mutations. Biotechniques 1993; 15:684-91.
13. Elston CW, Ellis IO. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991:19:403-10.
14. Falette N, Paperin M, Treilleux I, et al. Prognostic value of p53 gene mutations in a large series of node-negative 'breast cancer patients. Cancer Res 1998;58:1451-5.
15. Goldhirsch A, Glick JH, Gelber RD, Senn HJ. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1998;90:1601-8.
16. Hacia JG. Resequencing and mutational analysis using oligonucleotide microarrays. Nat Genet 1999;21(1 suppl):42-7.
17. Iacopetta B, Grieu F, Powell B, Soong R, McCaul K, Seshadri R. Analysis of p53 gene mutation by polymerase chain reaction single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin Can Res 1998; 4:1597-1602.
18. Iwahana H, Yoshimoto K, Mizusawa N, Kudo E, Itakura M. Multiple fluorescence-based PCR-SSCP analysis. Biotechniques 1994; 16:296-7.
19. Katsuragi K, Kitagishi K, Chiba W, Ikeda S, Kinoshita M. Fluorescence-based polymerase chain reaction-single-strand conformation polymorphism analysis of p53 gene by capillary electrophoresis. J Chromatography A 1996;744:311-20.
20. Kovach J, Hartmann A, Blaszyk H, et al. Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 1996;93:1093-6.
21. Makino R, Yazyu H, Kishimoto Y, Sekiya T, K Hayashi. F-SSCP: fluorescence-based polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis. Genome Res 1992;2:10-3.
22. Moyret C, Theillet C, Laurent-Puig P, et al. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 1994;9:1739-43.
23. O'Connell CD, Tian J, Juhasz A, Wenz HM, Atha DH. Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism. Electrophoresis 1998;19:164-71.
24. Schneider-Stock R, Haeckel C, Radig K, Pein CD, Roessner A. Improved detection of p53 mutations in soft tissue tumors using new gel composition for automated non-radioactive analysis of single-strand conformation polymorphism. Electrophoresis 1997; 18:2849-51.
25. Seshadri R, Leong A, McCaul K, et al. Relationship between p53 gene abnormalities and other tumor characteristics in breast cancer prognosis. Int J Cancer 1996;69:135-41.
26. Shiao Y-H, Chen V, Scheer W, Wu X, Correa P. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 1995;55:1485-90.
27. Soong R, Iacopetta B, Harvey J, et al. Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer. Int J Cancer 1997;74:642-7.
28. Soong R, Iacopetta B. A rapid and non-isotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed paraffin embedded tumors. Mod Pathol 1997;10:252-8.
29. Stenmark-Askmalm M, Stal O, Sullivan S, et al. Cellular accumulation of p53 protein: an independent prognostic factor in stage 11 breast cancer. Eur J Cancer 1994;2:175-80.
30. Thorlacius S, Borresen A-L, Eyfjord J. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res 1993;53:1637-41.
31. Wenz HM, Ramachandra S, O'Connell CD, Atha DH. Identification of known p53 point mutations by capillary electrophoresis using unique mobility profiles in a blinded study. Mutat Res 1998; 382:121-32.